Carregant...

Exploring genetic counselors’ perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM)

Pathogenic germline mutations in the BRCA1 or BRCA2 genes are associated with an elevated lifetime risk for breast (50–85% risk) and ovarian cancer (20–40% risk). Genome-wide association studies have identified over 100 genetic variants associated with modified breast and/or ovarian cancer risk in B...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Genet Couns
Autors principals: Heinlen, Christopher, Hovick, Shelly R., Brock, Guy N., Klamer, Brett G., Ewart Toland, Amanda, Senter, Leigha
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548677/
https://ncbi.nlm.nih.gov/pubmed/30843639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgc4.1079
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!